• EGFR and c-Met Inhibitors are Effective in Reducing Tumorigenicity in Cancer.  

    Stone A, Harrington K, Frakes M, Blank K, Rajanna S, Rastogi I, Puri N., Journal of Cancinogenesis, 2014

  • c-Met: A Potential Target for Current Non-Small-Cell Lung Cancer Therapeutics.  

    Stone A, Rajanna S, Rastogi I, Cruz J, Harrington K, Blank K, Frakes M, Puri N., Chemotherapy, 2014